729 related articles for article (PubMed ID: 32688395)
41. Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States.
Gupta S; Kaushik A; Gupta J
Monaldi Arch Chest Dis; 2020 Oct; 90(4):. PubMed ID: 33059413
[TBL] [Abstract][Full Text] [Related]
42. Coronavirus disease 2019 (COVID-19): a clinical update.
Zhou M; Zhang X; Qu J
Front Med; 2020 Apr; 14(2):126-135. PubMed ID: 32240462
[TBL] [Abstract][Full Text] [Related]
43. Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report.
Huang L; Wang Y; Wang L; Lv Y; Liu Q
Medicine (Baltimore); 2020 Jul; 99(27):e20956. PubMed ID: 32629703
[TBL] [Abstract][Full Text] [Related]
44. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
Zeng QL; Yu ZJ; Gou JJ; Li GM; Ma SH; Zhang GF; Xu JH; Lin WB; Cui GL; Zhang MM; Li C; Wang ZS; Zhang ZH; Liu ZS
J Infect Dis; 2020 Jun; 222(1):38-43. PubMed ID: 32348485
[TBL] [Abstract][Full Text] [Related]
45. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Wang D; Hu B; Hu C; Zhu F; Liu X; Zhang J; Wang B; Xiang H; Cheng Z; Xiong Y; Zhao Y; Li Y; Wang X; Peng Z
JAMA; 2020 Mar; 323(11):1061-1069. PubMed ID: 32031570
[TBL] [Abstract][Full Text] [Related]
46. Clinical findings in a patient with haemophilia A affected by COVID-19.
Cui D; Zhang A; Liu A; Hu Q
Haemophilia; 2020 Jul; 26(4):e214-e216. PubMed ID: 32239590
[No Abstract] [Full Text] [Related]
47. Convalescent plasma - Is it useful for treating SARS Co-V2 infection?
Ranganathan S; Iyer RN
Indian J Med Microbiol; 2020; 38(3 & 4):252-260. PubMed ID: 33154232
[TBL] [Abstract][Full Text] [Related]
48. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
[TBL] [Abstract][Full Text] [Related]
49. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Dequin PF; Heming N; Meziani F; Plantefève G; Voiriot G; Badié J; François B; Aubron C; Ricard JD; Ehrmann S; Jouan Y; Guillon A; Leclerc M; Coffre C; Bourgoin H; Lengellé C; Caille-Fénérol C; Tavernier E; Zohar S; Giraudeau B; Annane D; Le Gouge A;
JAMA; 2020 Oct; 324(13):1298-1306. PubMed ID: 32876689
[TBL] [Abstract][Full Text] [Related]
50. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study.
Luan YY; Liu Y; Liu XY; Yu BJ; Chen RL; Peng M; Ren D; Li HL; Huang L; Liu Y; Li JX; Feng YW; Wu M
Thromb Res; 2020 Nov; 195():62-68. PubMed ID: 32659462
[TBL] [Abstract][Full Text] [Related]
51. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
[TBL] [Abstract][Full Text] [Related]
52. Characteristics and Outcomes of COVID-19 Patients with Respiratory Failure Admitted to a "Pandemic Ready" Intensive Care Unit - Lessons from Singapore.
Chew SY; Lee YS; Ghimiray D; Tan CK; Chua GS
Ann Acad Med Singap; 2020 Jul; 49(7):434-448. PubMed ID: 33000106
[TBL] [Abstract][Full Text] [Related]
53. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic.
Lee NY; Li CW; Tsai HP; Chen PL; Syue LS; Li MC; Tsai CS; Lo CL; Hsueh PR; Ko WC
J Microbiol Immunol Infect; 2020 Jun; 53(3):485-487. PubMed ID: 32198005
[TBL] [Abstract][Full Text] [Related]
54. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
Kanagal-Shamanna R; Jain P; Patel KP; Routbort M; Bueso-Ramos C; Alhalouli T; Khoury JD; Luthra R; Ferrajoli A; Keating M; Jain N; Burger J; Estrov Z; Wierda W; Kantarjian HM; Medeiros LJ
Cancer; 2019 Feb; 125(4):559-574. PubMed ID: 30508305
[TBL] [Abstract][Full Text] [Related]
55. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
[TBL] [Abstract][Full Text] [Related]
56. Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL experts.
Koffman B; Mato A; Byrd JC; Danilov A; Hedrick B; Ujjani C; Roeker L; Stephens DM; Davids MS; Pagel JM; Shadman M
Am J Hematol; 2020 Aug; 95(8):E199-E203. PubMed ID: 32356356
[No Abstract] [Full Text] [Related]
57. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.
Shi M; Chen L; Yang Y; Zhang J; Xu J; Xu G; Li B; Yin Y
J Clin Lab Anal; 2020 Sep; 34(9):e23415. PubMed ID: 32488958
[TBL] [Abstract][Full Text] [Related]
58. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
Treon SP; Castillo JJ; Skarbnik AP; Soumerai JD; Ghobrial IM; Guerrera ML; Meid K; Yang G
Blood; 2020 May; 135(21):1912-1915. PubMed ID: 32302379
[No Abstract] [Full Text] [Related]
59. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
60. How likely are COVID-19 interventions to benefit the sickest patients?
Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B
Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
